Tag: MobiusHD

Newly Published Chronic Heart Failure Treatment Study Provides Promising Results for EVBA Procedure with Unique MobiusHD Device

IRVINE, Calif.–(BUSINESS WIRE)–Vascular Dynamics, Inc. (VDI), a privately held medical device company focused on developing game-changing endovascular device-based solutions for patients suffering from heart failure, announced that a study assessing its MobiusHD device to treat patients with chronic heart failure has been published in the peer-reviewed journal, Structural Heart. The findings and […]

First German EVBA Procedure is Performed with New Heart Failure Therapy Approach

Latest Data and Live Broadcast Show Promise of Vascular Dynamics’ MobiusHD Device IRVINE, Calif.–(BUSINESS WIRE)–Vascular Dynamics, Inc. (VDI), a privately held medical device company focused on developing game-changing endovascular device-based solutions for patients suffering from heart failure, announced that the endovascular baroreflex amplification (EVBA) procedure using its MobiusHD device to […]

Positive Preliminary Clinical Trial Results Reported for Vascular Dynamics’ Novel Heart Failure Treatment Technology

Endovascular baroreflex modulation data presented IRVINE, Calif.–(BUSINESS WIRE)–Vascular Dynamics, Inc., a privately held medical device company focused on innovative, endovascular device-based solutions for cardiovascular conditions, has announced positive preliminary results from its clinical trial, “A Feasibility Study Exploring the Effect of the MobiusHD® Device in Patients with Heart Failure.” Horst Sievert, […]

Data Published in The Lancet Shows Positive Results at Primary Endpoint in the Treatment of Resistant Hypertension with MobiusHD Device

MOUNTAIN VIEW, Calif., Sept. 01, 2017 (GLOBE NEWSWIRE) — Vascular Dynamics, Inc. (VDI), a privately held medical device company developing novel solutions for the treatment of hypertension, today announced European results of the company’s first-in-human trial of its MobiusHD®implant published in The Lancet.  The publication reported an average reduction of 24-hour […]